Cargando…
Immunotherapies for Malignant Glioma
Glioblastoma Multiforme (GBM) is a highly malignant primary brain cancer with a dreadful overall survival and for which treatment options are limited. Recent breakthroughs in novel immune-related treatment strategies for cancer have spurred interests in usurping the power of the patient's immun...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828703/ https://www.ncbi.nlm.nih.gov/pubmed/29242608 http://dx.doi.org/10.1038/s41388-017-0024-z |